Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rituximab: Don't Count It Out as MS Treatment
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
A comparative study of experimental mouse models of central nervous system demyelination.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
A genome screen for multiple sclerosis in Italian families.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
The International Symposium on the Multiple Sclerosis Brain
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.

Pages